-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Protagonist Therapeutics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- Protagonist Therapeutics, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$30.6M, a 20.4% increase year-over-year.
- Protagonist Therapeutics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $170M.
- Protagonist Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$79M, a 38% increase from 2022.
- Protagonist Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$127M, a 1.47% decline from 2021.
- Protagonist Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$126M, a 89.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)